Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022
Familial Cancer · 2024
DOI: 10.1007/s10689-024-00403-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Familial Cancer, 2024. Verfasst von Léa Guerrini-Rousseau und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. lea.guerrini-rousseau@gust…. Hauptthemen laut MEDLINE: Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biallelic germline pathogenic variants in one of the four mismatch repair genes ( MSH2 , MSH6 , MLH1 and PMS2 ) cause a very rare, highly penetrant, childhood-onset cancer syndrome, called constitutional mismatch repair deficiency (CMMRD). The European consortium “Care for CMMRD” (C4CMMRD) was founded in Paris in 2013 to facilitate international collaboration and improve our knowledge of this rare cancer predisposition syndrome. Following initial publications on diagnostic criteria and surveillance guidelines for CMMRD, several partners collaborating within the C4CMMRD consortium have worked on and published numerous CMMRD-related clinical and biological projects. Since its formation, the C4CMMRD consortium held meetings every 1–2 years (except in 2020 and 2021 due to the Covid 19 pandemic). The sixth C4CMMRD meeting was held in Paris in November 2022, and brought together 42 participants from nine countries involved in various fields of CMMRD healthcare. The aim was to update members on the latest results and developments from ongoing research, and to discuss and initiate new study proposals. As previously done for the fifth meeting of the C4CMMRD group, this report summarizes data presented at this meeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. lea.guerrini-rousseau@gustaveroussy.fr.
- Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif, France. lea.guerrini-rousseau@gustaveroussy.fr.
- Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain.
- Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
- Inserm U1245, Univ Rouen Normandie, Rouen, France.
Zitieren
APA
Guerrini-Rousseau, L., Gallon, R., Pineda, M., Brugières, L., Baert-Desurmont, S., Corsini, C., Dangouloff-Ros, V., Gorris, M. A. J., Haberler, C., Hoarau, P., Jongmans, M. C., Kloor, M., Loeffen, J., Rigaud, C., Robbe, J., Vibert, R., Weijers, D., Wimmer, K., Colas, C., & Care For CMMRD consortium (2024). Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022. Familial Cancer. https://doi.org/10.1007/s10689-024-00403-1
Vancouver
Guerrini-Rousseau L, Gallon R, Pineda M, Brugières L, Baert-Desurmont S, Corsini C, et al. Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022. Familial Cancer. 2024. doi:10.1007/s10689-024-00403-1
BibTeX
@article{GuerriniRousseau2024,
author = {Guerrini-Rousseau, Léa and Gallon, Richard and Pineda, Marta and Brugières, Laurence and Baert-Desurmont, Stéphanie and Corsini, Carole and Dangouloff-Ros, Volodia and Gorris, Mark A J and Haberler, Christine and Hoarau, Pauline and Jongmans, Marjolijn C and Kloor, Matthias and Loeffen, Jan and Rigaud, Charlotte and Robbe, Julie and Vibert, Roseline and Weijers, Dilys and Wimmer, Katharina and Colas, Chrystelle and Care For CMMRD consortium, Care For CMMRD consortium},
title = {Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022},
journal = {Familial Cancer},
year = {2024},
doi = {10.1007/s10689-024-00403-1}
}
EUVIMED